EMA Call for participants in ATMP development
The European Medicines Agency (EMA) has initiated a pilot program to help non-commercial developers of advanced therapy medicinal products (ATMPs) to navigate EU regulatory requirements and better understand their needs. Eventually, participants are expected to reach the marketing authorisation application stage.
After a first round in 2021 and a second one in 2023, the EMA is looking for two new candidates among ATMP academic researchers for their program 2024 program. Potential developer candidates can apply by completing the application form available in the link below or contact the agency via atmppilot@ema.europa.eu to express their interest.
👉 Apply now on: https://www.ema.europa.eu/en/news/progress-update-pilot-academic-non-profit-developers-advanced-therapy-medicines